Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Idiopathic ventricular fibrillation].

P Chevalier1, P Touboul

  • 1Hôpital cardiovasculaire et pneumologique, 28, avenue du Doyen-Lépine, Lyon-Montchat.

Archives Des Maladies Du Coeur Et Des Vaisseaux
|May 18, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Arrhythmogenic cardiomyopathy as a myogenic disease: highlights from cardiomyocytes derived from human induced pluripotent stem cells.

Frontiers in physiology·2023
Same author

Visual and Hearing Sensitivity Affect Robot-Based Training for Children Diagnosed With Autism Spectrum Disorder.

Frontiers in robotics and AI·2022
Same author

Direct thermo-optical tuning of silicon microresonators for the mid-infrared.

Optics express·2019
Same author

Truncating mutations on myofibrillar myopathies causing genes as prevalent molecular explanations on patients with dilated cardiomyopathy.

Clinical genetics·2017
Same author

Prevalence of drug-related problems associated with direct oral anticoagulants in hospitalized patients: a multicenter, cross-sectional study.

Journal of clinical pharmacy and therapeutics·2016
Same author

Cost of a Pulmonary Arterial Hypertension-Related Hospitalization in Belgium.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2016
Same journal

Radiokymographic study of the kinetics of the middle arc and the hils in the normal subject.

Archives des maladies du coeur et des vaisseaux·2010
Same journal

A medication for angina pectoris and pre-fibrillatory conditions; 1262 F; six years of clinical experience; action mechanism.

Archives des maladies du coeur et des vaisseaux·2010
Same journal

Circulatory changes following the injection of hypertonic saline solutions; application to the study of angina pectoris.

Archives des maladies du coeur et des vaisseaux·2010
Same journal

Alterations in coronary circulation during aortic insufficiency in young subjects.

Archives des maladies du coeur et des vaisseaux·2010
Same journal

Cardio-esophageal auscultation.

Archives des maladies du coeur et des vaisseaux·2010
Same journal

Hypertensive accidents following the injection of acetylcholine.

Archives des maladies du coeur et des vaisseaux·2010
See all related articles

Idiopathic ventricular fibrillation, often without structural heart issues, encompasses conditions like Brugada syndrome. Research aims to clarify management choices between drugs and defibrillators for these complex cases.

Area of Science:

  • Cardiology
  • Genetics
  • Electrophysiology

Context:

  • Ventricular fibrillation (VF) survivors sometimes lack identifiable structural cardiac abnormalities.
  • Idiopathic ventricular fibrillation (IVF) is a diagnosis of exclusion, encompassing diverse underlying conditions.

Purpose:

  • To delineate distinct electro-clinical entities within IVF, including Brugada syndrome, short-coupled torsades de pointes, catecholaminergic polymorphic ventricular tachycardia, and acquired long QT syndrome.
  • To discuss the management strategies for these conditions, highlighting challenges in treatment choices.

Summary:

  • The article reviews specific conditions causing idiopathic ventricular fibrillation.
  • While the pathophysiology of many IVF causes remains unclear, established management protocols exist for some.

Related Experiment Videos

  • A significant challenge remains in selecting between pharmacological therapy and automatic implantable cardioverter-defibrillators for numerous patients.

    • Impact:

    • Future molecular studies and standardized clinical investigations are crucial for developing a rational treatment approach for idiopathic ventricular fibrillation.
    • Improved understanding and standardized approaches can lead to better patient outcomes in managing life-threatening arrhythmias.